By BY REBECCA ROBBINS AND PAM BELLUCK from NYT The agency faced criticism for approving Aduhelm for all Alzheimer’s patients. The new label recommends that the drug be given only to patients with mild symptoms.Health https://ift.tt/3wpL7KI
via
In a Reversal, F.D.A. Calls for Limits on Who Gets Alzheimer’s Drug
By BY REBECCA ROBBINS AND PAM BELLUCK from NYT The agency faced criticism for approving Aduhelm for all Alzheimer’s patients. The new label recommends that the drug be given only to patients with mild symptoms.Health https://ift.tt/3wpL7KI
via
0 comments:
Post a Comment